lipid nanoparticles

SAN CARLOS, Calif., May 22, 2026 Eli Lilly and Company has acquired Engage Bio, a preclinical biotechnology company focused...

MENLO PARK, California, May 20, 2026 ReCode Therapeutics announced positive clinical data from its RCT1100 inhaled mRNA therapy program...

CAMBRIDGE, Mass., May 14, 2026 Mirai Bio presented new preclinical data at the American Society of Gene and Cell...

CAMBRIDGE, Mass., May 12, 2026 Mirai Bio unveiled new preclinical data at the American Society of Gene and Cell...

BOSTON, Massachusetts, May 2026 Kernal Biologics announced it will present new data on its mRNA 2.0 platform and T-cell-targeted...

CAMBRIDGE, Mass., April 27, 2026 Mirai Bio announced it will unveil two next-generation programs focused on targeted nucleic acid...

ESSEN/MUNICH, Germany, September 9, 2025 – Evonik and Ethris have entered a strategic partnership to enhance RNA-based therapeutic solutions...